Kati Talvinen
Turku, 20500, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Personalized multifactorial risk assessment in neoadjuvant-treated breast carcinoma.
Journal: Breast cancer research and treatment
Published: October 28, 2024
Varying outcomes of triple-negative breast cancer in different age groups-prognostic value of clinical features and proliferation.
Journal: Breast cancer research and treatment
Published: August 02, 2022
A prognostic model based on cell-cycle control predicts outcome of breast cancer patients.
Journal: BMC cancer
Published: January 20, 2020
Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer.
Journal: Journal of cancer research and clinical oncology
Published: August 23, 2019
Proliferation-associated miRNAs-494, -205, -21 and -126 detected by in situ hybridization: expression and prognostic potential in breast carcinoma patients.
Journal: Journal of cancer research and clinical oncology
Published: November 28, 2017
Separase is a marker for prognosis and mitotic activity in breast cancer.
Journal: British journal of cancer
Published: May 05, 2017
PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival.
Journal: BMC cancer
Published: August 18, 2016
Prognostic implications of securin expression and sub-cellular localization in human breast cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 01, 2016
Low cdc27 and high securin expression predict short survival for breast cancer patients.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: October 05, 2012
Securin predicts aneuploidy and survival in breast cancer.
Journal: Histopathology
Published: January 21, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026